32 studies found for:    " August 22, 2007":" September 21, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 22, 2007":" September 21, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
2 Completed
Has Results
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
Condition: Human Immunodeficiency Virus - Type 1
Interventions: Drug: Darunavir (DRV);   Drug: Ritonavir (rtv)
3 Unknown  A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Condition: HIV Infections
Intervention: Biological: EP1090
4 Terminated HIV - Monotherapy in Switzerland (MOST-ch)
Condition: HIV Infections
Interventions: Drug: Lopinavir-Monotherapy;   Drug: HAART
5 Completed Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
Condition: HIV Infections
Intervention: Procedure: Infant feeding counseling that includes Flash-heat
6 Completed Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Condition: HIV Infections
Intervention: Biological: Biologically active recombinant Tat protein
7 Completed A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV
Condition: HIV Infections
Interventions: Behavioral: MBSR group;   Other: Control
8 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
9 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
10 Completed Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults
Condition: HIV Infections
Interventions: Biological: PennVax B;   Biological: IL-12;   Biological: IL-15
11 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
12 Completed
Has Results
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Conditions: Genital Herpes;   HIV Infection
Interventions: Drug: valacyclovir;   Drug: acyclovir
13 Completed Bioequivalency Study of Zidovudine Under Fasting Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
14 Withdrawn Epoetin Alfa for HIV-Associated Neuropathy Trial
Conditions: HIV Infections;   Neuropathy
Intervention: Drug: epoetin alfa
15 Completed Double Protease Inhibitor to Darunavir Switch Study
Condition: HIV Infections
Intervention: Drug: Darunavir ritonavir
16 Completed Bioequivalency Study of Zidovudine Under Fed Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
17 Terminated A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: efavirenz or nevirapine
18 Completed Interactions Between HIV and Malaria in African Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: Dihydroartemisinin-piperaquine;   Drug: Artemether-lumefantrine;   Drug: Trimethoprim-sulfamethoxazole
19 Completed Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
Condition: HIV Infections
Interventions: Drug: darunavir;   Drug: Emtricitabine/tenofovir DF;   Drug: Maraviroc;   Drug: Raltegravir
20 Completed Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years